Variation of Serum PSA Levels in COVID-19 Infected Male Patients with Benign Prostatic Hyperplasia (BPH): A Prospective Cohort Studys.

ABSTRACT:

Objective

To investigate the effect of SARS CoV-2 on serum total PSA levels in men with BPH diagnosed with COVID-19.

Methods

The PSA (Kit: Immunoassay Program- Cycle 18, Siemens Atellica IM Analyzer) levels in patients who had had a PSA check at least 3 months, but no more than 6 months, prior to diagnosis of acute COVID-19 infection, were examined retrospectively. PSA levels were measured and recorded from these patients on the first day of diagnosis of COVID-19. These patients were called back for urology outpatient follow-up at the third month after the end of the COVID-19 treatment. PSA levels measured in the pre-COVID-19 period, during the period of active infection with COVID-19, and in the post-COVID-19 period were compared.

Results

In total, 91 patients had a

SUBMITTER: Cinislioglu AE 

PROVIDER: S-EPMC8493783 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature